N
Next Biomedical
Q3 2026 earnings expected
Quarter
Jul – Sep
Expected
November 14, 2026(KST)
Revenue
This quarter₩5.6B
Year ago (Sep '25)₩4.9B▲ +13.5%
Operating Income
Turned to a loss
This quarter-₩2.8B
Year ago (Sep '25)₩370M
Revenue Growth Trajectory
+24%YoY
Last 6 quarters
Next quarter net income -₩2.4B est.